Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase
- 1 July 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (14) , 1991-1996
- https://doi.org/10.1016/s0960-894x(99)00323-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Ras Farnesyltransferase: A New Therapeutic TargetJournal of Medicinal Chemistry, 1997
- Inhibition of ras prenylation: A novel approach to cancer chemotherapyPharmacology & Therapeutics, 1997
- Patent Update Oncologic, Endocrine & Metabolic: Oncologic, Endocrine & Metabolic: Inhibitors of protein farnesylationExpert Opinion on Therapeutic Patents, 1996
- Review Oncologic, Endocrine & Metabolic: Inhibitors of protein farnesylation: A new approach to cancer chemotherapyExpert Opinion on Therapeutic Patents, 1995
- Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceNature Medicine, 1995
- Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeuticCell, 1994
- Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase InhibitorScience, 1993
- Ras C-terminal processing enzymes—New drug targets?Cell, 1991
- Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptidesCell, 1990
- ras GENESAnnual Review of Biochemistry, 1987